山东医药
山東醫藥
산동의약
Shandong Medical Journal
2015年
37期
4-6
,共3页
徐宝宁%宋成洋%邹孔军%田大力
徐寶寧%宋成洋%鄒孔軍%田大力
서보저%송성양%추공군%전대력
肺肿瘤%胸腔镜%围手术期%预后
肺腫瘤%胸腔鏡%圍手術期%預後
폐종류%흉강경%위수술기%예후
video-assisted mini-thoracotomy%non-small-cell lung cancer%perioperative period%prognosis
目的:探讨电视胸腔镜辅助微创切口肺癌根治术治疗非小细胞肺癌的临床效果及预后。方法回顾性分析95例电视胸腔镜辅助微创切口肺癌根治术(微创组)与94例传统开胸肺癌根治术(常规组)患者的临床资料,对比两组疗效及预后。结果微创组术中出血量、引流管留置时间、镇痛药使用次数、术后并发症及术后住院时间均少于常规组(P均<0.05);两组手术时间、淋巴结清除数差异无统计学意义(P均>0.05);两组术后无疾病进展生存期和总生存期差异无统计学意义(P均>0.05)。结论电视胸腔镜辅助微创切口肺癌根治术治疗非小细胞肺癌可完成肿瘤的彻底切除和系统淋巴结清扫,在远期疗效上亦不逊于常规开胸手术,且创伤小、恢复快。
目的:探討電視胸腔鏡輔助微創切口肺癌根治術治療非小細胞肺癌的臨床效果及預後。方法迴顧性分析95例電視胸腔鏡輔助微創切口肺癌根治術(微創組)與94例傳統開胸肺癌根治術(常規組)患者的臨床資料,對比兩組療效及預後。結果微創組術中齣血量、引流管留置時間、鎮痛藥使用次數、術後併髮癥及術後住院時間均少于常規組(P均<0.05);兩組手術時間、淋巴結清除數差異無統計學意義(P均>0.05);兩組術後無疾病進展生存期和總生存期差異無統計學意義(P均>0.05)。結論電視胸腔鏡輔助微創切口肺癌根治術治療非小細胞肺癌可完成腫瘤的徹底切除和繫統淋巴結清掃,在遠期療效上亦不遜于常規開胸手術,且創傷小、恢複快。
목적:탐토전시흉강경보조미창절구폐암근치술치료비소세포폐암적림상효과급예후。방법회고성분석95례전시흉강경보조미창절구폐암근치술(미창조)여94례전통개흉폐암근치술(상규조)환자적림상자료,대비량조료효급예후。결과미창조술중출혈량、인류관류치시간、진통약사용차수、술후병발증급술후주원시간균소우상규조(P균<0.05);량조수술시간、림파결청제수차이무통계학의의(P균>0.05);량조술후무질병진전생존기화총생존기차이무통계학의의(P균>0.05)。결론전시흉강경보조미창절구폐암근치술치료비소세포폐암가완성종류적철저절제화계통림파결청소,재원기료효상역불손우상규개흉수술,차창상소、회복쾌。
Objective To investigate the clinical efficacy of video-assisted mini-thoracotomy ( VAMT) in the treat-ment of non-small-cell lung cancer ( NSCLC) and the prognosis .Methods Ninety-five patients treated with VAMT ( mini-mally invasive group ) and 94 patients treated with conventional thoracotomy ( conventional group ) received the radical re-section of pulmonary carcinoma .The clinical data of the two groups were retrospectively analyzed and we compared the cur -ative effect and the prognosis of the two groups .Results The blood loss , drainage tube indwelling time , the frequency of using analgesics , postoperative complications and postoperative hospital stay in patients of the minimally invasive group were less than those of the conventional group , and significant difference was found between the two groups (all P<0.05). No statistically significant differences were found in the operative time and the number of lymph nodes removed between the two groups (all P>0.05).There were no significant differences in the overall survival after surgery and progression -free survival between the two groups (all P>0.05).Conclusions VAMT in the treatment of NSCLC can complete the radical resection of the tumor and the lymph node system .The long-term effect of VAMT is not inferior to the conventional thoracot-omy, including less trauma and faster recovery .